US4067777A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Determination of heparin in the blood
Assignee: Individual
•
Filing: 1976-05-13
•
Granted: 1978-01-10
•
Expires: 1996-05-13
Abstract
Abstract Heparin in the blood is determined over a wide range of concentrations by measuring the clotting time of serum derived from a test specimen of blood when combined under standard conditions with thrombin and plasma solutions. The clotting time is then determined from an experimentally-established functional relationship between clotting time and heparin concentration.
Inventors
- 👤 Irving Innerfield, deceased
- 👤 executrix by H. Jean Innerfield
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 15:54
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/86; G01N2400/00; G01N2400/10; G01N2400/38; G01N2400/40; Y; Y10; Y10T; Y10T436/00; Y10T436/10; Y10T436/108331
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
245 words
A method of determining the concentration of heparin in blood in heparinized patients, comprising the steps of equilibrating normal human plasma at a selected temperature, adding serum from said blood to standardized thrombin solution and incubating the resultant thrombin-serum mixture at said selected temperature and for a selected period, said period at said selected temperature being such as to be too brief for substantial reaction between said thrombin and any fibrin degradation products in said serum while sufficient for reaction of heparin with said thrombin, adding a standard portion of said incubated thrombin-serum mixture to said plasma under conditions such as to produce an essentially uniform thrombin-serum-plasma mixture, observing the clotting time thereof, said clotting time being an inverse function of the quantity of thrombin remaining after reaction with said heparin and thereby a direct function of the concentration of heparin in said blood, and comparing the thus-determined clotting time with a curve prepared by adding different quantities of heparin to serum specimens taken from healthy individuals to form heparin-serum solutions, adding each heparin-serum solution to thrombin solution and incubating for said selected period at said selected temperature, adding the incubated heparin-serum-thrombin solution to normal plasma incubated at said selected temperature and noting the clotting time, thereby determining clotting times as a function of heparin content of serum, thus making it possible to specify the heparin content of a patient's blood by measuring the clotting time of serum taken from the blood of said patient.
Claim 2
Independent Claim
245 words
A method of determining the concentration of heparin in blood in heparinized patients, comprising the steps of equilibrating normal human plasma at a selected temperature, adding serum from said blood to standardized thrombin solution and incubating the resultant thrombin-serum mixture at said selected temperature and for a selected period, said period at said selected temperature being such as to be too brief for substantial reaction between said thrombin and any fibrin degradation products in said serum while sufficient for reaction of heparin with said thrombin, adding a standard portion of said incubated thrombin-serum mixture to said plasma under conditions such as to produce an essentially uniform thrombin-serum-plasma mixture, observing the clotting time thereof, said clotting time being an inverse function of the quantity of thrombin remaining after reaction with said heparin and thereby a direct function of the concentration of heparin in said blood, and comparing the thus-determined clotting time with a curve prepared by adding different quantities of heparin to serum specimens taken from healthy individuals to form heparin-serum solutions, adding each heparin-serum solution to thrombin solution and incubating for said selected period at said selected temperature, adding the incubated heparin-serum-thrombin solution to normal plasma incubated at said selected temperature and noting the clotting time, thereby determining clotting times as a function of heparin content of serum, thus making it possible to specify the heparin content of a patient's blood by measuring the clotting time of serum taken from the blood of said patient.
Claim 3
Dependent Claim
24 words
The method as defined in claim 1, wherein the temperature of equilibration of said plasma and incubation of said thrombin-serum mixture is 37° C.
Claim 4
Dependent Claim
47 words
The method as defined in claim 1, wherein said thrombin solution is prepared by reconstituting solid thrombin and diluting same until 0.1 ml of the diluted thrombin solution when mixed with 0.2 ml of fresh normal plasma at 37° C has a clotting time of 12 seconds.
Claim 5
Dependent Claim
26 words
The method as defined in claim 1, wherein said serum is prepared by normal clotting and centrifugation followed by incubation at 37° C for 1/2 hour.
Claim 6
Dependent Claim
19 words
The method as defined in claim 2 wherein the time of incubation of said thrombin-serum mixture is 2 minutes.
Claim 7
Independent Claim
219 words
A method of determining the concentration of heparin in blood in heparinized patients, comprising the steps of equilibrating normal human plasma at a selected temperature, adding serum from said blood to standardized thrombin solution and incubating the resultant thrombin-serum mixture at said selected temperature for a selected period long enough to bring said thrombin-serum mixture essentially to said selected temperature, adding a standard portion of said incubated thrombin-serum mixture to said plasma under conditions such as to produce an essentially uniform thrombin-serum-plasma mixture, observing the clotting time thereof, said clotting time being an inverse function of the quantity of thrombin remaining after reaction with said heparin and thereby a direct function of the concentration of heparin in said blood, and comparing the thus-determined clotting time with a curve prepared by adding different quantities of heparin to serum specimens taken from healthy individuals to form heparin-serum solutions, adding each heparin-serum solution to thrombin solution and incubating for said period at said selected temperature, adding the incubated heparin-serum-thrombin solution to normal plasma incubated at said selected temperature and noting the clotting time, thereby determining clotting times as a function of heparin content of serum, thus making it possible to specify the heparin content of a patient's blood by measuring the clotting time of serum taken from the blood of said patient.
Claim 8
Independent Claim
219 words
A method of determining the concentration of heparin in blood in heparinized patients, comprising the steps of equilibrating normal human plasma at a selected temperature, adding serum from said blood to standardized thrombin solution and incubating the resultant thrombin-serum mixture at said selected temperature for a selected period long enough to bring said thrombin-serum mixture essentially to said selected temperature, adding a standard portion of said incubated thrombin-serum mixture to said plasma under conditions such as to produce an essentially uniform thrombin-serum-plasma mixture, observing the clotting time thereof, said clotting time being an inverse function of the quantity of thrombin remaining after reaction with said heparin and thereby a direct function of the concentration of heparin in said blood, and comparing the thus-determined clotting time with a curve prepared by adding different quantities of heparin to serum specimens taken from healthy individuals to form heparin-serum solutions, adding each heparin-serum solution to thrombin solution and incubating for said period at said selected temperature, adding the incubated heparin-serum-thrombin solution to normal plasma incubated at said selected temperature and noting the clotting time, thereby determining clotting times as a function of heparin content of serum, thus making it possible to specify the heparin content of a patient's blood by measuring the clotting time of serum taken from the blood of said patient.
References Cited (Backward Citations)
US3853710A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1981-01-09 | 1981-07-11 | 1982-01-10 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1985-01-09 | 1985-07-11 | 1986-01-10 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1989-01-09 | 1989-07-11 | 1990-01-10 | $7700.00 | Window Closed / Lapsed |